*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.
*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.
*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.
As communities navigate the winter respiratory virus season, state and local health leaders are updating response plans to protect older adults, individuals with underlying medical conditions, and underserved populations. With vaccination rates declining and continued confusion about changing government guidance, the timely use of COVID-19 and influenza antivirals remains a critical, yet often underused, tool to reduce severe illness, preserve hospital capacity, and limit outbreaks.
CVEEP convened a webinar featuring a panel of clinical, public health, and community experts for a discussion of the latest guidance, any anticipated rise in COVID-19 infections, and how linking antiviral use to overall outbreak response plans can strengthen community preparedness. Participants gained practical insights to support testing-to-treatment pathways, align provider and pharmacy coordination, and promote access to care this respiratory season.
Panelists included:
